...
首页> 外文期刊>Molecules >In-Silico Analyses of Sesquiterpene-Related Compounds on Selected Leishmania Enzyme-Based Targets
【24h】

In-Silico Analyses of Sesquiterpene-Related Compounds on Selected Leishmania Enzyme-Based Targets

机译:选定的利什曼原虫酶为靶标的倍半萜烯相关化合物的硅内分析

获取原文
   

获取外文期刊封面封底 >>

       

摘要

A great number of sesquiterpenes are reported in the available literature as good antileishmanial leads. However, their mode of action at the molecular level has not been elucidated. The lack of molecular studies could be considered an impediment for studies seeking to improve sesquiterpene-based drug design. The present in silico study allows us to make important observations about the molecular details of the binding modes of a set of antileishmanial sesquiterpenes against four drug-enzyme targets [pteridine reductase-1 (PTR1), N-myristoyl transferase (NMT), cysteine synthase (CS), trypanothione synthetase (TryS)]. Through molecular docking it was found that two sesquiterpene coumarins are promising leads for the PTR1 and TryS inhibition purposes, and some xanthanolides also exhibited better affinity towards PTR1 and CS binding. In addition, the affinity values were clustered by Principal Component Analysis and drug-like properties were analyzed for the strongest-docking sesquiterpenes. The results are an excellent starting point for future studies of structural optimization of this kind of compounds.
机译:现有文献中报道了许多倍半萜烯作为良好的抗衰老药线索。但是,尚未阐明它们在分子水平上的作用方式。缺乏分子研究可能被认为是试图改善基于倍半萜的药物设计的研究的障碍。目前的计算机模拟研究使我们能够对一组抗菊苣倍半萜与四种药物酶靶标[蝶啶还原酶-1(PTR1),N-肉豆蔻酰基转移酶(NMT),半胱氨酸合酶》的结合模式的分子细节进行重要观察。 (CS),锥虫硫醇合成酶(TryS)]。通过分子对接,发现两种倍半萜香豆素是用于PTR1和TryS抑制目的的有前途的先导,并且一些黄嘌呤内酯对PTR1和CS的结合也表现出更好的亲和力。另外,通过主成分分析对亲和力值进行聚类,并分析了对接最强的倍半萜烯的类药物特性。该结果是此类化合物结构优化未来研究的一个极好的起点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号